What Did This CEO Just Do with Personal Shares of Neurometrix (NURO)?


Today, the President & CEO of Neurometrix (NASDAQ: NURO), Shai Gozani, sold shares of NURO for $4,436.

This is Gozani’s first Sell trade following 32 Buy transactions.

See today’s analyst top recommended stocks >>

Based on Neurometrix’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $3.67 million and quarterly net profit of $1.09 million. In comparison, last year the company earned revenue of $3.55 million and had a GAAP net loss of $3.51 million. Currently, Neurometrix has an average volume of 31.57K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts